PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29123088-0	2017	A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer.	Paclitaxel	34-44	nucleolin	Homo sapiens	16-25	
29123088-3	2017	Here we design and synthesize a highly water-soluble nucleolin aptamer-paclitaxel conjugate (NucA-PTX) that selectively delivers PTX to the tumor site.	Paclitaxel	71-81	nucleolin	Homo sapiens	53-62	
29123088-3	2017	Here we design and synthesize a highly water-soluble nucleolin aptamer-paclitaxel conjugate (NucA-PTX) that selectively delivers PTX to the tumor site.	Paclitaxel	98-101	nucleolin	Homo sapiens	53-62	
29123088-3	2017	Here we design and synthesize a highly water-soluble nucleolin aptamer-paclitaxel conjugate (NucA-PTX) that selectively delivers PTX to the tumor site.	Paclitaxel	129-132	nucleolin	Homo sapiens	53-62	
29123088-4	2017	By connecting a tumor-targeting nucleolin aptamer (NucA) to the active hydroxyl group at 2" position of PTX via a cathepsin B sensitive dipeptide bond, NucA-PTX remains stable and inactive in the circulation.	Paclitaxel	104-107	nucleolin	Homo sapiens	32-41	
29123088-4	2017	By connecting a tumor-targeting nucleolin aptamer (NucA) to the active hydroxyl group at 2" position of PTX via a cathepsin B sensitive dipeptide bond, NucA-PTX remains stable and inactive in the circulation.	Paclitaxel	157-160	nucleolin	Homo sapiens	32-41